Clinical Trial Update: Comparative Efficacy of 100-, 200-, & 400-mg Amiodarone in Patients With Paroxysmal AF Depending on Plasma Concentration [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is comparing 100-, 200-, and 400-mg daily doses of amiodarone in patients with paroxysmal atrial fibrillation to evaluate efficacy as a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• Amiodarone (amiodarone)

Snippet

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences | Conditions: Paroxysmal AF, Treatment Decisions | Phase 4 | Status: ENROLLING_BY_INVITATION